A Retrospective Study of the Efficacy of Albendazole and Diethylcarbamazine for the Treatment of Human Toxocariasis
In the Department of Parasitology and Mycology of Toulouse University Hospitals, patients presenting with common/covert toxocariasis were treated either with albendazole (39 cases) or with diethylcarbamazine (32 cases). Albendazole (ABZ) was given at 10 mg/kg b/w daily for 14 days, and diethylcarbam...
Main Authors: | Jean-François Magnaval, Judith Fillaux, Antoine Berry |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/11/7/813 |
Similar Items
-
Therapy and Prevention for Human Toxocariasis
by: Jean-François Magnaval, et al.
Published: (2022-01-01) -
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021-03-01) -
Human toxocariasis and atopy
by: Magnaval Jean-François, et al.
Published: (2020-01-01) -
Disseminated toxocariasis in an immunocompetent host
by: Madan Raj Aryal, et al.
Published: (2014-10-01) -
A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.
by: Belizario V.Y., et al.
Published: (2003-01-01)